>全球单基因疾病检测市场，按检测类型（携带者检测、诊断检测、新生儿筛查、预测性和症状前检测、产前检测）、疾病类型（囊性纤维化、镰状细胞性贫血、严重联合免疫缺陷 (SCID)、泰-萨克斯病、多囊肾病、戈谢病、亨廷顿病、神经纤维瘤病、地中海贫血、家族性高胆固醇血症）、最终用途（医院、门诊手术中心、专科诊所）划分 - 行业趋势和预测到 2029 年。
单基因疾病检测市场分析和规模
植入前单基因疾病基因检测 (PGT-M) 是辅助生殖计划中针对被确定为具有高风险遗传孟德尔疾病患者的一项预防性检测。一个人的 DNA 序列中的单个基因突变会导致单基因疾病。它们可能导致出生缺陷、智力、感官或运动障碍。这些疾病会影响患者的生活质量和寿命。不幸的是，单基因疾病无法治疗或治愈。
Data Bridge Market Research 分析，单基因疾病检测市场预计在 2022 年至 2029 年的预测期内将达到 11% 的复合年增长率。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解之外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
单基因疾病检测市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制为 2014 - 2019） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
检测类型（携带者检测、诊断检测、新生儿筛查、预测性和症状前检测、产前检测）、疾病类型（囊性纤维化、镰状细胞性贫血、严重联合免疫缺陷 (SCID)、泰-萨克斯病、多囊肾病、戈谢病、亨廷顿病、神经纤维瘤病、地中海贫血、家族性高胆固醇血症）、最终用途（医院、门诊手术中心、专科诊所） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲的其他地区。 |
|
涵盖的市场参与者 |
Celera Support Services (U.S.), Abbott (U.S.), ELITech Group (U.S.), Quest Diagnostics Incorporated (U.S.), Auto Genomics (U.S.), PerkinElmer Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.) |
|
Market Opportunities |
|
Market Definition
Monogenetic disorders are inherited due to a single defective gene on the autosomes, according to Mendel's Laws. Monogenic disorders are caused by a single mutated gene that can be found on either one or both chromosomes. This disorder affects both men and women equally, because of autosomal conditions. Cystic fibrosis, sickle cell anaemia, SCID, Tay-sachs disease, polycystic kidney disease, Gaucher's disease, Huntington's disease, neurofibromatosis, thalassaemia, and familial hypercholesterolemia are among the common monogenic disorders for which tests are available.
Global Monogenic Disease Testing Market Dynamics
Drivers
- Rising monogenic disorders
The monogenic disorder is caused by a leucine for serine substitution at codon 810 of the MR. 15. This mutation changes the shape and specificity of the MR and eliminates the usual requirement for the 21-hydroxyl group of aldosterone to interact with the MR, which explains other steroids, such as progesterone, activate the MR and spironolactone, which is normally an antagonist of the MR, acts as an agonist in this disorder. All these are the factors which boost the growth of the market.
- Increased usage of monogenic disease testing
The highly developed technological platforms and enhanced genomic tools are expected to have a significant impact on the monogenic disease testing market in the forecast period of 2022 to 2029. Another significant reason for the increased usage of monogenic disease testing has been the increased exclusive opportunity that require more research on monogenic disease tests.
Opportunities
- Technological advancements
The rising prevalence of monogenic disorders around the world will provide ample opportunities for the growth of the monogenic disease testing market during the forecast period. For instance, CACNA1A (FHM1), which is located on chromosome 19p13 and codes for the 1 subunit of neuronal CaV2.1 (P/Q-type) voltage-gated calcium channels, was the first FHM gene discovered. These channels can be found all over the CNS. FHM has been linked to over 20 different missense mutations in this gene. Aside from hemiplegic migraine, these mutations are frequently linked to other phenotypes such as cerebellar ataxia and epilepsy.
Restraints/Challenges
- Lack of trained professionals
Lack of trained professionals and dearth of knowledge, a false result can destroy a person's life and can even lead home to death ill obstruct the market's growth rate.
本单基因病检测市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关单基因病检测市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。
全球单基因疾病检测市场范围
单基因疾病检测市场根据检测类型、疾病类型和最终用途进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
测试类型
- 携带者检测
- 诊断测试
- 新生儿筛查
- 预测性和症状前检测
- 产前检查
疾病类型
- 囊性纤维化
- 镰状细胞性贫血
- 严重联合免疫缺陷 (SCID)
- 泰-萨克斯病
- 多囊肾病
- 戈谢氏病
- 亨廷顿氏病
- 神经纤维瘤病
- 地中海贫血
- 家族性高胆固醇血症
最终用途
- 医院
- 门诊手术中心
- 专科诊所
单基因疾病检测市场区域分析/见解
对单基因疾病检测市场进行了分析，并按国家、检测类型、疾病类型和最终用途提供了市场规模见解和趋势。
单基因疾病检测市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于人们的智力水平很高且对单基因疾病检测程序的认识不断提高，北美在单基因疾病检测市场中占据主导地位。
由于有大量专注于疾病管理的组织，预计亚太地区将在 2022 年至 2029 年的预测期内以最高的增长率增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
单基因疾病检测市场还为您提供每个国家/地区资本设备医疗支出增长、单基因疾病检测市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗监管情景的变化及其对单基因疾病检测市场的影响的详细市场分析。数据涵盖 2010-2020 年的历史时期。
竞争格局和单基因疾病检测市场份额分析
单基因疾病检测市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对单基因疾病检测市场的关注有关。
单基因疾病检测市场的一些主要参与者包括：
- Celera 支持服务（美国）
- 雅培（美国）
- ELITech 集团 (美国)
- Quest Diagnostics Incorporated（美国）
- Auto Genomics（美国）
- PerkinElmer Inc.（美国）
- F. Hoffmann-La Roche Ltd（瑞士）
- Bio-Rad Laboratories, Inc.（美国）
- 赛默飞世尔科技公司（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
